|
C1ORF103 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.824700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.178800E-03 |
| Normal-vs-Stage2 |
1.780980E-01 |
| Normal-vs-Stage3 |
7.134600E-01 |
| Normal-vs-Stage4 |
6.107800E-01 |
| Stage1-vs-Stage2 |
3.448400E-01 |
| Stage1-vs-Stage3 |
8.785500E-02 |
| Stage1-vs-Stage4 |
1.182760E-01 |
| Stage2-vs-Stage3 |
4.783400E-01 |
| Stage2-vs-Stage4 |
2.569600E-01 |
| Stage3-vs-Stage4 |
4.591800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.759800E-04 |
| Normal-vs-AfricanAmerican |
2.032300E-02 |
| Normal-vs-Asian |
3.211000E-01 |
| Caucasian-vs-AfricanAmerican |
4.516800E-01 |
| Caucasian-vs-Asian |
1.593980E-01 |
| AfricanAmerican-vs-Asian |
1.794570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.536990E-03 |
| Normal-vs-Female |
8.142000E-01 |
| Male-vs-Female |
1.722460E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.958300E-03 |
| Normal-vs-Extreme_Weight |
1.801010E-03 |
| Normal-vs-Obese |
6.023800E-02 |
| Normal-vs-Extreme_Obese |
8.044900E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.706000E-01 |
| Normal_Weight-vs-Obese |
6.365000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.335400E-01 |
| Extreme_Weight-vs-Obese |
2.077200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.479200E-01 |
| Obese-vs-Extreme_Obese |
6.170200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.849400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.094400E-02 |
| Normal-vs-Age(61-80Yrs) |
9.178100E-04 |
| Normal-vs-Age(81-100Yrs) |
3.043800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.880200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.751590E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.086400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.084140E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.560800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.846000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.177100E-03 |
| Normal-VS-Type2 PRCC |
5.196500E-04 |
| Normal-VS-KIRP CIMP |
3.6719999999546E-06 |
| Normal-VS-Unclassified PRCC |
1.572270E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.667200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.403800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.539200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.965600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.521800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.367600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.056650E-03 |
| Normal-vs-N1 |
2.572400E-01 |
| Normal-vs-N2 |
5.899200E-01 |
| N0-vs-N1 |
6.664300E-03 |
| N0-vs-N2 |
2.800400E-01 |
| N1-vs-N2 |
4.375600E-01 |
|
|
